{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:26:05Z","timestamp":1790623565615,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA 048530"],"award-info":[{"award-number":["DA 048530"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is evidence of the therapeutic potential of intranasal oxytocin for the treatment of pain and various psychiatric disorders, however, there is scant evidence that oxytocin reaches the brain. We quantified the concentration and distribution pattern of [<jats:sup>125<\/jats:sup>I]-radiolabeled oxytocin in the brains and peripheral tissues of rats after intranasal delivery using gamma counting and autoradiography, respectively. Radiolabel was detected in high concentrations in the trigeminal and olfactory nerves as well as in brain regions along their trajectories. Considerable concentrations were observed in the blood, however, relatively low levels of radiolabel were measured in peripheral tissues. The addition of a mucoadhesive did not enhance brain concentrations. These results provide support for intranasal OT reaching the brain via the olfactory and trigeminal neural pathways. These findings will inform the design and interpretation of clinical studies with intranasal oxytocin.<\/jats:p>","DOI":"10.1038\/s41398-021-01511-7","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T18:02:51Z","timestamp":1625940171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations"],"prefix":"10.1038","volume":"11","author":[{"given":"David C.","family":"Yeomans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean S.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-9612","authenticated-orcid":false,"given":"Brendan J.","family":"Tunstall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Z.","family":"Tzabazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-0794","authenticated-orcid":false,"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/mp.2014.74","volume":"20","author":"Y Aoki","year":"2015","unstructured":"Aoki Y, Watanabe T, Abe O, Kuwabara H, Yahata N, Takano Y, et al. Oxytocin\u2019s neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial. Mol Psychiatry. 2015;20:447\u2013453.","journal-title":"Mol Psychiatry"},{"key":"1511_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/AJP.0b013e31829f57df","volume":"30","author":"JA Rash","year":"2014","unstructured":"Rash JA, Aguirre-Camacho A, Campbell TS. Oxytocin and pain a systematic review and synthesis of findings. Clin J Pain. 2014;30:453\u2013462.","journal-title":"Clin J Pain."},{"key":"1511_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0269881112473788","volume":"27","author":"DS Carson","year":"2013","unstructured":"Carson DS, Guastella AJ, Taylor ER, McGregor IS. A brief history of oxytocin and its role in modulating psychostimulant effects. J Psychopharmacol. 2013;27:231\u2013247.","journal-title":"J Psychopharmacol."},{"key":"1511_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnins.2013.00035","volume":"7","author":"K MacDonald","year":"2013","unstructured":"MacDonald K, Feifel D. Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders. Front Neurosci. 2013;7:7.","journal-title":"Front Neurosci."},{"key":"1511_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv. Rev. 2012;64:614\u2013628.","journal-title":"Adv Drug Deliv. Rev."},{"key":"1511_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2nd. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127:481\u2013496.","journal-title":"Neuroscience"},{"key":"1511_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","volume":"152","author":"RG Thorne","year":"2008","unstructured":"Thorne RG, Hanson LR, Ross TM, Tung D, Frey WH 2nd. Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience. 2008;152:785\u2013797.","journal-title":"Neuroscience"},{"key":"1511_CR8","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/jps.21604","volume":"98","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH II. Intranasal drug targeting of hypocretin-1 (Orexin-A) to the central nervous system. J Pharm Sci. 2009;98:2501\u20132515.","journal-title":"J Pharm Sci."},{"key":"1511_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopsych.2017.04.015","volume":"82","author":"FB Spengler","year":"2017","unstructured":"Spengler FB, Schultz J, Scheele D, Essel M, Maier W, Heinrichs M, et al. Kinetics and dose dependency of intranasal oxytocin effects on amygdala reactivity. Biol Psychiatry. 2017;82:885\u2013894.","journal-title":"Biol Psychiatry"},{"key":"1511_CR10","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41386-019-0582-6","volume":"45","author":"J Lieberz","year":"2020","unstructured":"Lieberz J, Scheele D, Spengler FB, Matheisen T, Schneider L, Stoffel-Wagner B, et al. Kinetics of oxytocin effects on amygdala and striatal reactivity vary between women and men. Neuropsychopharmacology. 2020;45:1134\u20131140.","journal-title":"Neuropsychopharmacology"},{"key":"1511_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/mp.2017.27","volume":"23","author":"MR Lee","year":"2018","unstructured":"Lee MR, Scheidweiler KB, Diao XX, Akhlaghi F, Cummins A, Huestis MA, et al. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Mol Psychiatry. 2018;23:115\u2013122.","journal-title":"Mol Psychiatry"},{"key":"1511_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnins.2014.00041","volume":"8","author":"O Dal Monte","year":"2014","unstructured":"Dal Monte O, Noble PL, Costa VD, Averbeck BB. Oxytocin enhances attention to the eye region in rhesus monkeys. Front Neurosci. 2014;8:41.","journal-title":"Front Neurosci."},{"key":"1511_CR13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1073\/pnas.1114621109","volume":"109","author":"SW Chang","year":"2012","unstructured":"Chang SW, Barter JW, Ebitz RB, Watson KK, Platt ML. Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta). Proc Natl Acad Sci USA. 2012;109:959\u2013964.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1511_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep03440","volume":"3","author":"N Striepens","year":"2013","unstructured":"Striepens N, Kendrick KM, Hanking V, Landgraf R, W\u00fcllner U, Maier W, et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep. 2013;3:3440.","journal-title":"Sci Rep."},{"key":"1511_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.biopsych.2015.05.003","volume":"79","author":"G Leng","year":"2016","unstructured":"Leng G, Ludwig M. Intranasal oxytocin: myths and delusions. Biol Psychiatry. 2016;79:243\u2013250.","journal-title":"Biol Psychiatry"},{"key":"1511_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0006-8993(83)90478-X","volume":"262","author":"WB Mens","year":"1983","unstructured":"Mens WB, Witter A, van Wimersma TB. Greidanus, Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res. 1983;262:143\u2013149.","journal-title":"Brain Res"},{"key":"1511_CR17","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.psyneuen.2013.03.003","volume":"38","author":"ID Neumann","year":"2013","unstructured":"Neumann ID, Maloumby R, Beiderbeck DI, Lukas M, Landgraf R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology. 2013;38:1985\u20131993.","journal-title":"Psychoneuroendocrinology"},{"key":"1511_CR18","doi-asserted-by":"publisher","first-page":"104324","DOI":"10.1016\/j.phrs.2019.104324","volume":"146","author":"AS Smith","year":"2019","unstructured":"Smith AS, Korgan AC, Young WS. Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice. Pharm Res. 2019;146:104324.","journal-title":"Pharm Res"},{"key":"1511_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15942-1","volume":"11","author":"MR Lee","year":"2020","unstructured":"Lee MR, Shnitko TA, Blue SW, Kaucher AV, Winchell AJ, Erikson DW, et al. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques. Nat Commun. 2020;11:2783.","journal-title":"Nat Commun."},{"key":"1511_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1177\/0333102415618615","volume":"36","author":"A Tzabazis","year":"2016","unstructured":"Tzabazis A, Mechanic J, Miller J, Klukinov M, Pascual C, Manering N, et al. Oxytocin receptor: expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders. Cephalalgia. 2016;36:943\u2013950.","journal-title":"Cephalalgia"},{"key":"1511_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.neuron.2017.06.003","volume":"95","author":"L Xiao","year":"2017","unstructured":"Xiao L, Priest MF, Nasenbeny J, Lu T, Kozorovitskiy Y. Biased oxytocinergic modulation of midbrain dopamine systems. Neuron. 2017;95:368\u2013384.","journal-title":"Neuron"},{"key":"1511_CR22","doi-asserted-by":"crossref","unstructured":"Burgos-Vega C, Moy J, Dussor G., Price TJ, Dussor G. Chapter Eighteen-Meningeal afferent signaling and the pathophysiology of migraine Progress in molecular biology and translational science. Cambridge, Massachusetts. 2015;537\u2013564.","DOI":"10.1016\/bs.pmbts.2015.01.001"},{"key":"1511_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.yfrne.2009.05.004","volume":"30","author":"HE Ross","year":"2009","unstructured":"Ross HE, Young LJ. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front Neuroendocrinol. 2009;30:534\u2013547.","journal-title":"Front Neuroendocrinol."},{"key":"1511_CR24","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1152\/physrev.00031.2017","volume":"98","author":"B Jurek","year":"2018","unstructured":"Jurek B, Neumann ID. The oxytocin receptor: from intracellular signaling to behavior. Physiological Rev. 2018;98:1805\u20131908.","journal-title":"Physiological Rev."},{"key":"1511_CR25","doi-asserted-by":"publisher","first-page":"e2006421","DOI":"10.1371\/journal.pbio.2006421","volume":"17","author":"BJ Tunstall","year":"2019","unstructured":"Tunstall BJ, Kirson D, Zallar LJ, McConnell SA, Vendruscolo J, Ho CP, et al. Oxytocin blocks enhanced motivation for alcohol in alcohol dependence and blocks alcohol effects on GABAergic transmission in the central amygdala. PLoS Biol. 2019;17:e2006421.","journal-title":"PLoS Biol."},{"key":"1511_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fnbeh.2015.00245","volume":"9","author":"CF Ferris","year":"2015","unstructured":"Ferris CF, Yee JR, Kenkel WM, Dumais KM, Moore K, Veenema AH, et al. Distinct BOLD activation profiles following central and peripheral oxytocin administration in awake rats. Front Behav Neurosci. 2015;9:245.","journal-title":"Front Behav Neurosci."},{"key":"1511_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0196-9781(98)00047-3","volume":"19","author":"DE Dluzen","year":"1998","unstructured":"Dluzen DE, Muraoka S, Engelmann M, Landgraf R. The effects of infusion of arginine vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses in male rats. Peptides. 1998;19:999\u20131005.","journal-title":"Peptides"},{"key":"1511_CR28","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1210\/en.2014-1148","volume":"155","author":"JM Ho","year":"2014","unstructured":"Ho JM, Anekonda VT, Thompson BW, Zhu M, Curry RW, Hwang BH, et al. Hindbrain oxytocin receptors contribute to the effects of circulating oxytocin on food intake in male rats. Endocrinology. 2014;155:2845\u20132857.","journal-title":"Endocrinology"},{"key":"1511_CR29","doi-asserted-by":"crossref","unstructured":"Jiang CY, Fujita T, Kumamoto E. Synaptic modulation and inward current produced by oxytocin in substantia gelatinosa neurons of adult rat spinal cord slices. J Neurophysiol. 2014;111:991\u20131007.","DOI":"10.1152\/jn.00609.2013"},{"issue":"Suppl 2","key":"1511_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/head.13082","volume":"57","author":"A Tzabazis","year":"2017","unstructured":"Tzabazis A, Kori S, Mechanic J, Miller J, Pascual C, Manering N, et al. Oxytocin and migraine. Headache Headache. 2017;57(Suppl 2):64\u201375.","journal-title":"Headache Headache"},{"key":"1511_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/j.pain.0000000000000808","volume":"158","author":"A Kubo","year":"2017","unstructured":"Kubo A, Shinoda M, Katagiri A, Takeda M, Suzuki T, Asaka J, et al. Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia. Pain. 2017;158:649\u2013659.","journal-title":"Pain"},{"key":"1511_CR32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1177\/0333102415618615","volume":"36","author":"A Tzabazis","year":"2016","unstructured":"Tzabazis A, Mechanic J, Miller J, Klukinov M, Pascual C, Manering N, et al. Oxytocin receptor: expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders. Cephalalgia. 2016;36:943\u2013950.","journal-title":"Cephalalgia"},{"key":"1511_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yhbeh.2018.12.011","volume":"108","author":"A Oppong-Damoah","year":"2019","unstructured":"Oppong-Damoah A, Zaman RU, D\u2019Souza MJ, Murnane KS. Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin. Horm Behav. 2019;108:20\u201329.","journal-title":"Horm Behav."},{"key":"1511_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","volume":"143","author":"F Erd\u0151","year":"2018","unstructured":"Erd\u0151 F, Bors LA, Farkas D, Bajza \u00c1, Gizurarson S. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull. 2018;143:155\u2013170.","journal-title":"Brain Res Bull."},{"key":"1511_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64:614\u2013628.","journal-title":"Adv Drug Deliv Rev."},{"key":"1511_CR36","doi-asserted-by":"publisher","first-page":"104325","DOI":"10.1016\/j.phrs.2019.104325","volume":"146","author":"MT Bowen","year":"2019","unstructured":"Bowen MT. Does peripherally administered oxytocin enter the brain? Compelling new evidence in a long-running debate. Pharmacol Res. 2019;146:104325.","journal-title":"Pharmacol Res."},{"key":"1511_CR37","doi-asserted-by":"publisher","first-page":"e12963","DOI":"10.1111\/jne.12963","volume":"33","author":"S-i Munesue","year":"2021","unstructured":"Munesue S-i, Liang M, Harashima A, Zhong J, Furuhara K, Boitsova EB, et al. Transport of oxytocin to the brain after peripheral administration by membrane-bound or soluble forms of receptors for advanced glycation end-products. J Neuroendocrinol. 2021;33:e12963.","journal-title":"J Neuroendocrinol."},{"key":"1511_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s42003-019-0325-6","volume":"2","author":"Y Yamamoto","year":"2019","unstructured":"Yamamoto Y, Liang M, Munesue S, Deguchi K, Harashima A, Furuhara K, et al. Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice. Commun Biol. 2019;2:76.","journal-title":"Commun Biol"},{"key":"1511_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14845-5","volume":"11","author":"DA Martins","year":"2020","unstructured":"Martins DA, Mazibuko N, Zelaya F, Vasilakopoulou S, Loveridge J, Oates A, et al. Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans. Nat Commun. 2020;11:1160.","journal-title":"Nat Commun."},{"key":"1511_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpharm.2011.05.054","volume":"415","author":"GH Zhao","year":"2011","unstructured":"Zhao GH, Kapur N, Carlin B, Selinger E, Guthrie JT. Characterisation of the interactive properties of microcrystalline cellulose-carboxymethyl cellulose hydrogels. Int J Pharm. 2011;415:95\u2013101.","journal-title":"Int J Pharm."},{"key":"1511_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jcpa.2015.08.009","volume":"153","author":"R Chamanza","year":"2015","unstructured":"Chamanza R, Wright JA. A review of the comparative anatomy, histology, physiology and pathology of the nasal cavity of rats, mice, dogs and non-human primates. Relevance to inhalation toxicology and human health risk assessment. J Comp Pathol. 2015;153:287\u2013314.","journal-title":"J Comp Pathol."},{"key":"1511_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000299248","volume":"16","author":"L Vankrieken","year":"1983","unstructured":"Vankrieken L, Godart A, Thomas K. Oxytocin determination by radioimmunoassay. Gynecol Obstet Invest. 1983;16:180\u2013185.","journal-title":"Gynecol Obstet Invest"},{"key":"1511_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1054-3589(04)50014-5","volume":"50","author":"BB McEwen","year":"2004","unstructured":"McEwen BB. Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research. Adv Pharm. 2004;50:531\u2013592. 655-708","journal-title":"Adv Pharm."},{"key":"1511_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","volume":"61","author":"E Hollander","year":"2007","unstructured":"Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, et al. Oxytocin increases retention of social cognition in autism. Biol Psychiatry. 2007;61:498\u2013503.","journal-title":"Biol Psychiatry"},{"key":"1511_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.npp.1300021","volume":"28","author":"E Hollander","year":"2003","unstructured":"Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger\u2019s disorders. Neuropsychopharmacology. 2003;28:193\u2013198.","journal-title":"Neuropsychopharmacology"},{"key":"1511_CR46","doi-asserted-by":"crossref","unstructured":"Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS ONE. 2011;6:e27237.","DOI":"10.1371\/journal.pone.0027237"},{"key":"1511_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuropharm.2009.06.018","volume":"58","author":"DS Carson","year":"2010","unstructured":"Carson DS, Cornish JL, Guastella AJ, Hunt GE, McGregor IS. Oxytocin decreases methamphetamine self-ad ministration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology. 2010;58:38\u201343.","journal-title":"Neuropharmacology"},{"key":"1511_CR48","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1369-1600.2010.00247.x","volume":"15","author":"DS Carson","year":"2010","unstructured":"Carson DS, Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC, et al. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biol. 2010;15:448\u2013463.","journal-title":"Addiction Biol."},{"key":"1511_CR49","doi-asserted-by":"publisher","first-page":"R360","DOI":"10.1152\/ajpregu.00344.2014","volume":"308","author":"Y Iwasaki","year":"2015","unstructured":"Iwasaki Y, Maejima Y, Suyama S, Yoshida M, Arai T, Katsurada K, et al. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity. Am J Physiol Regul Integr Comp Physiol. 2015;308:R360\u2013369.","journal-title":"Am J Physiol Regul Integr Comp Physiol."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01511-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:24:00Z","timestamp":1669901040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01511-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01511-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,10]]},"assertion":[{"value":"3 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism. BJT received funding from the National Institutes of Health grant number DA 048530. Partial funding was also provided by a grant from Trigemina, Inc. DCY, DJ, and WHF II are founders and shareholders of Trigemina, Inc. DSC is a shareholder of Trigemina, Inc. AT is a consultant and shareholder of Trigemina, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}